Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email

Yin Liu, Ph.D.

Program Director
Division of Cancer Biology (DCB)
Cancer Immunology, Hematology, and Etiology Branch
240-276-6229
|
liuy@mail.nih.gov

Dr. Yin Liu has expertise and manages a grant portfolio in T cell exhaustion, Inflammation and tissue homeostasis in cancer, autoimmunity and immune-related adverse events (irAEs), lymphocyte migration, and T cell receptor signaling. 

Along with his work in DCB, Dr. Liu co-chairs a Cancer Moonshot Implementation Team. 

 

Research Programs:

Dr. Liu is involved in NCI research programs and a Cancer Moonshot initiative:

Background

Prior to his work as a DCB program director, Dr. Liu was a scientific review officer at  the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Before working as a science administrator, he was a scientist in the NIH intramural research program, where he was involved in research about T cell receptor signaling, regulation of lymphocyte cytoskeleton and lymphocyte migration, and autoinflammatory diseases caused by genetic mutations.

He came to DCB because of the opportunity to support the field of immunotherapy. 
 

Education

  • Ph.D., Immunology, The Fourth Military Medical Institute  


     

  • Updated:
Email